• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The appropriate use of NSAIDs in arthritic conditions.

作者信息

Moskowitz R W

机构信息

Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Am J Orthop (Belle Mead NJ). 1996 Sep;25(9 Suppl):4-6.

PMID:8886211
Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are an important component of therapy for many of the arthritides. They are of value in the treatment of rheumatoid arthritis (RA) and other arthritides with inflammatory characteristics and are frequently used to treat osteoarthritis (OA) when simple analgesics fail to provide relief. There is a great deal of interpatient variability with respect to response to NSAIDs; however, it is currently difficult to predict which patient will respond best to which drug. As a result, NSAID selection is based both on the medical history of the individual patient and the adverse-events profiles of the available agents. In general, patients on NSAIDs should be monitored closely for adverse events, particularly those patients with a history of, or risk factors for, gastrointestinal, renal, or hepatic disease. Use of the cytoprotective agent misoprostol is indicated in patients at high risk for gastrointestinal irritation. Although H2-antagonists in high dosages may be effective in the prophylaxis of gastropathy, there is some concern that use of these agents at usual dose levels may create a potential for adverse events by masking the pain associated with ongoing gastric erosive changes.

摘要

相似文献

1
The appropriate use of NSAIDs in arthritic conditions.
Am J Orthop (Belle Mead NJ). 1996 Sep;25(9 Suppl):4-6.
2
A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.针对西米德兰兹郡风湿病诊所使用COX - 2选择性非甾体抗炎药(NSAIDs)情况与英国国家卫生与临床优化研究所(NICE)指南相关的一项区域性审计。
Rheumatology (Oxford). 2005 Jul;44(7):921-4. doi: 10.1093/rheumatology/keh642. Epub 2005 Apr 12.
3
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.类风湿关节炎非甾体抗炎药治疗的胃肠道并发症。一项前瞻性观察队列研究。
Arch Intern Med. 1996 Jul 22;156(14):1530-6.
4
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.骨关节炎和类风湿关节炎患者症状性治疗的新方向。
Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):4-14. doi: 10.1053/sarh.2002.37215.
5
An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference.骨关节炎和类风湿关节炎治疗中开具非甾体抗炎药的循证方法:第二届加拿大共识会议
Can J Clin Pharmacol. 2000 Autumn;7 Suppl A:4A-16A.
6
Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.骨关节炎和类风湿关节炎患者低剂量使用乙酰水杨酸、对乙酰氨基酚和布洛芬导致严重胃肠道事件的发生率。
J Rheumatol. 2003 Oct;30(10):2226-33.
7
HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.HZT-501(DUEXIS(®);布洛芬 800mg/法莫替丁 26.6mg)在治疗类风湿关节炎和骨关节炎的体征和症状中的胃肠道保护作用。
Expert Rev Gastroenterol Hepatol. 2012 Feb;6(1):25-35. doi: 10.1586/egh.11.88.
8
A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.韩国关节炎患者抗关节炎药物的横断面回顾性评估。
Curr Med Res Opin. 2003;19(7):597-602. doi: 10.1185/030079903125002252.
9
The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.类风湿关节炎和骨关节炎患者胃肠道不良事件的比较风险及预测因素:一项对2131例患者进行的为期13年的前瞻性研究
J Rheumatol. 2000 Jul;27(7):1668-73.
10
Clinical experience with cyclooxygenase-2 inhibitors.环氧化酶-2抑制剂的临床经验
Rheumatology (Oxford). 2002 Apr;41 Supp 1:16-22; discussion 35-42.

引用本文的文献

1
Therapeutic effect of Streptococcus thermophilus CRL 1190-fermented milk on chronic gastritis.嗜热链球菌 CRL 1190 发酵乳对慢性胃炎的治疗作用。
World J Gastroenterol. 2010 Apr 7;16(13):1622-30. doi: 10.3748/wjg.v16.i13.1622.